CorMedix (CRMD) PT Lowered to $9 at RBC Capital

March 13, 2024 6:21 AM

RBC Capital analyst Gregory Renza lowered the price target on CorMedix (NASDAQ: CRMD) to $9.00 (from $10.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found